Baptist Heart Services Receives Honor from Duke
Baptist was one of only 10 percent of hospitals nationwide receiving the Outstanding Care Award by Duke Clinical Research Institute for the CRUSADE project.
Jackson, MS (PRWEB) December 19 2003--Baptist Heart Services, a division of
Baptist Health Systems in Jackson, Miss., received an Outstanding Care Award
from CRUSADE, a nationwide registry of heart patients with acute coronary
syndromes (ACS) coordinated by Duke Clinical Research Institute. Medical
Director for the University of Mississippi Medical Center’s Emergency Department
Dr. Richard Summers presented the award to Baptist. He serves as a CRUSADE
steering committee member for Duke Clinical Research Institute. Millennium
Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge,
Mass., and Schering-Plough Corporation are funding Duke’s research for CRUSADE
and hosted the award ceremony.
Baptist entered into CRUSADE nationwide
quality improvement initiative in November 2001. This national program analyzes
and modifies treatment patterns of over 70,000 patients suffering from chest
pain across the United States. Baptist is one of 600 hospitals across the US
participating in CRUSADE. The registry continually gathers data from
participating hospitals and provides feedback to the hospitals with a goal of
improving outcomes for ACS. Only 10 percent of participating hospitals
nationwide were awarded this recognition.
“This award signifies that
Baptist consistently practices high-quality, evidence-based medicine for
high-risk cardiac patients,” said Baptist Vice President of Clinical Services
Steve Jackson. At the “heart” of the initiative is its emphasis on new treatment
guidelines recently released by the American College of Cardiology and the
American Heart Association. The guidelines call for the earliest possible
determination—in the Emergency Room—of the patient’s risk for a serious cardiac
event such as a heart attack or stroke. They also prescribe what symptoms and
tests should be used to evaluate risk and specify treatments that correspond to
the risk level when it is determined.
“Our chest pain evaluation process
helps us rapidly identify the cause of chest pain and improve the care of
high-risk patients with heart disease,” said Jackson.
Baptist’s award was
for the period April 1, 2002 to March 31, 2003.
# # #
Source : http://www.prweb.com/releases/2003/12/prweb94999.htm